BRIEF—Flash Therapeutics appoints new president

French biotech Flash Therapeutics has appointed Jerome Bedier as president.

The firm is focused on the design and bioproduction of lentiviral vectors, serving developers of gene, cell, RNA and vaccine therapies.

Mr Bedier was formerly biopharma president at Novasep's biopharmaceutical business, and was most recently chief operating officer at Cell-Easy.

Flash has a proprietary GMP technology platform for developing lentiviral vectors and is backed by investors such as TechLife Capital and Auriga Partners.